In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40 ...

A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...

Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use ...

A UAB-led study finds that multiple myeloma returning within three years of intensive frontline treatment should be ...

When multiple myeloma returns after a period of remission, treatment plans often need to be adjusted because the cancer may have become resistant to previous medications. Doctors determine the most ...

Panelists discuss how treatment decisions in multiple myeloma are guided by disease risk, patient health, and evolving clinical data—highlighting the shift toward a comprehensive, multi-phase approach ...

Darzalex (daratumumab) is a biologic medication used to treat a type of blood cancer called multiple myeloma in adults. Doctors use it for people who have just been diagnosed, as well as for patients ...

For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide ...

Modern multiple myeloma treatment often involves complex combination therapies, which significantly impact daily life for patients and care partners. Modern multiple myeloma treatment often involves ...

Study Amplifies United Kingdom Hematologist Perspectives on Access, Funding, and Treatment Decision-Making in Multiple ...

Chemotherapy is a treatment that uses strong medicines to kill cancer cells or slow their growth. It is a type of systemic therapy, which means it travels through the bloodstream to reach and attack ...